title: Influence of lipid composition on the structural stability of g-protein coupled receptor.
abstract: β2 Adrenergic receptor (β2AR) is a kind of G-protein coupled receptors (GPCRs) which transduce a wide range of extracellular signals into intracellular messages responsible for the regulation of diverse cell functions. Because of their functional ubiquity, GPCR is one of the most important drug targets in pharmaceutical industry. Although recent crystallographic studies provided both the active and the inactive states of some families of GPCRs, the influence of lipid composition of bilayer membrane on their activation is still poorly understood. In this work, we address the influence of lipid composition on the structural stability of GPCR, performing molecular dynamics simulations of three kinds of states: apo-, and agonist epinephrine-, or antagonist alprenolol-bound β2AR. These three kinds of β2ARs were embedded in four types of lipid membranes: (i) pure palmitoyl-oleoyl-phosphatidyl-choline (POPC), (ii) POPC/cholesterol (CHL), (iii) POPC/CHL/GM1 (GM1 ganglioside), (iv) POPC/palmitoyl-oleoyl-phosphatidyl-ethanolamine (POPE)/CHL/sphingomyeline (SM). The side chains of Lys267(6.29) and Asp331(7.58) showed different conformations among the three states in all types of lipid membranes. The distances between Lys267(6.29) and Asp331(7.58) of apo- and alprenolol-bound β2ARs are smaller than that of the epinephrine-bound β2AR. In contrast, β2ARs in POPC/CHL bilayer were unstable in which the salt bridge; i.e., ionic lock, was not formed between Arg131(3.50) and Glu268(6.30). We have also examined the distribution of lipid molecules. A stable hydrophobic interaction between CHL and β2AR was observed at transmembrane helix5 in POPC/CHL/GM1 and POPC/POPE/CHL/SM membranes. These results suggest that the lipid composition strongly affects the conformation of GPCR and essentially concerns the GPCR activation.
authors.affiliation: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
authors.forename: Iqbal
authors.initials: I
authors.lastname: Mahmood
authors.forename: Xinli
authors.initials: X
authors.lastname: Liu
authors.forename: Saburo
authors.initials: S
authors.lastname: Neya
authors.forename: Tyuji
authors.initials: T
authors.lastname: Hoshino
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000737:chemistry / Q000378:metabolism; D058672:Adrenergic beta-2 Receptor Antagonists / Q000737:chemistry / Q000378:metabolism; D000526:Alprenolol / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D002784:Cholesterol / Q000737:chemistry / Q000378:metabolism; D004837:Epinephrine / Q000737:chemistry / Q000378:metabolism; D005677:G(M1) Ganglioside / Q000737:chemistry / Q000378:metabolism; D057927:Hydrophobic and Hydrophilic Interactions; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism*; D056004:Molecular Dynamics Simulation; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D055550:Protein Stability; D017434:Protein Structure, Tertiary; D018343:Receptors, Adrenergic, beta-2 / Q000737:chemistry / Q000378:metabolism*
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D058672:Adrenergic beta-2 Receptor Antagonists; D008051:Lipid Bilayers; D010713:Phosphatidylcholines; D018343:Receptors, Adrenergic, beta-2; D005677:G(M1) Ganglioside; D000526:Alprenolol; D002784:Cholesterol; C028694:1-palmitoyl-2-oleoylphosphatidylcholine; D004837:Epinephrine